Rigel Pharmaceuticals reported $22.51M in Trade Creditors for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Agenus AGEN:US USD 40.94M 1.23M
Anika Therapeutics ANIK:US USD 9.07M 721K
Arrowhead Research ARWR:US USD 796K 2.07M
Celldex Therapeutics CLDX:US USD 3.34M 1.07M
Daiichi Sankyo 4568:JP JPY 358.38B 26.16B
Halozyme Therapeutics HALO:US USD 17.69M 473K
Heron Therapeutics HRTX:US USD 6.55M 7.26M
Immunogen IMGN:US USD 45.35M 25.17M
Intrexon XON:US USD 4.07M 133K
Macrogenics MGNX:US USD 4.9M 280K
Rigel Pharmaceuticals RIGL:US USD 22.51M 19.79M
Sangamo Biosciences SGMO:US USD 22.42M 5.04M
Ultragenyx Pharmaceutical RARE:US USD 43.27M 19.74M
Veracyte VCYT:US USD 11.91M 797K